Barclays PLC Icon PLC Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Icon PLC stock. As of the latest transaction made, Barclays PLC holds 15,767 shares of ICLR stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,767

Previous 15,767 -0.0%

Holding current value

$3.36 Million

Previous $4.53 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$280.48 - $346.2 $1.2 Million - $1.48 Million	4,281 Added 37.27%	15,767 $4.53 Million
Q2 2024 Aug 14, 2024	SELL	$288.23 - $331.73 $25 Million - $28.8 Million	-86,676 Reduced 88.3%	11,486 $3.6 Million
Q1 2024 May 15, 2024	BUY	$247.84 - $340.0 $2.33 Million - $3.2 Million	9,410 Added 10.6%	98,162 $33 Million
Q4 2023 Feb 15, 2024	BUY	$222.83 - $285.76 $601,863 - $771,837	2,701 Added 3.14%	88,752 $25.1 Million
Q3 2023 Nov 07, 2023	BUY	$236.44 - $265.62 $12.7 Million - $14.3 Million	53,696 Added 165.96%	86,051 $21.2 Million
Q2 2023 Aug 03, 2023	BUY	$183.12 - $250.2 $3.83 Million - $5.24 Million	20,930 Added 183.19%	32,355 $8.1 Million
Q1 2023 May 04, 2023	BUY	$193.59 - $245.33 $1,355 - $1,717	7 Added 0.06%	11,425 $2.44 Million
Q4 2022 Feb 13, 2023	BUY	$173.9 - $224.8 $631,604 - $816,473	3,632 Added 46.65%	11,418 $2.22 Million
Q3 2022 Nov 03, 2022	SELL	$183.25 - $247.5 $367,782 - $496,732	-2,007 Reduced 20.49%	7,786 $1.43 Million
Q2 2022 Aug 12, 2022	BUY	$197.3 - $261.32 $480,228 - $636,052	2,434 Added 33.08%	9,793 $2.12 Million
Q1 2022 May 16, 2022	BUY	$216.09 - $296.03 $634,008 - $868,552	2,934 Added 66.31%	7,359 $1.79 Million
Q4 2021 Feb 14, 2022	SELL	$258.11 - $309.7 $2.17 Million - $2.6 Million	-8,404 Reduced 65.51%	4,425 $1.37 Million
Q3 2021 Nov 09, 2021	SELL	$208.53 - $283.04 $2.21 Million - $3 Million	-10,587 Reduced 45.21%	12,829 $3.36 Million
Q2 2021 Aug 13, 2021	BUY	$194.07 - $232.2 $4.15 Million - $4.97 Million	21,402 Added 1062.66%	23,416 $4.84 Million
Q1 2021 May 13, 2021	SELL	$171.87 - $220.96 $298,194 - $383,365	-1,735 Reduced 46.28%	2,014 $396,000
Q4 2020 Feb 11, 2021	SELL	$180.3 - $214.08 $32,093 - $38,106	-178 Reduced 4.53%	3,749 $731,000
Q3 2020 Nov 12, 2020	SELL	$166.91 - $196.1 $399,916 - $469,855	-2,396 Reduced 37.89%	3,927 $750,000
Q2 2020 Aug 12, 2020	SELL	$129.79 - $170.94 $1.73 Million - $2.28 Million	-13,357 Reduced 67.87%	6,323 $1.07 Million
Q1 2020 May 13, 2020	SELL	$115.95 - $177.22 $772,227 - $1.18 Million	-6,660 Reduced 25.28%	19,680 $2.68 Million
Q4 2019 Feb 10, 2020	BUY	$139.48 - $172.23 $152,870 - $188,764	1,096 Added 4.34%	26,340 $4.54 Million
Q3 2019 Nov 14, 2019	BUY	$146.89 - $161.41 $192,425 - $211,447	1,310 Added 5.47%	25,244 $3.72 Million
Q2 2019 Aug 14, 2019	SELL	$129.99 - $153.97 $686,997 - $813,731	-5,285 Reduced 18.09%	23,934 $3.68 Million
Q1 2019 May 15, 2019	SELL	$121.3 - $146.95 $13,949 - $16,899	-115 Reduced 0.39%	29,219 $3.99 Million
Q4 2018 Feb 14, 2019	SELL	$119.37 - $153.29 $483,567 - $620,977	-4,051 Reduced 12.13%	29,334 $3.79 Million
Q3 2018 Nov 14, 2018	SELL	$131.3 - $153.75 $3.97 Million - $4.65 Million	-30,245 Reduced 47.53%	33,385 $5.13 Million
Q2 2018 Aug 14, 2018	SELL	$111.38 - $137.03 $600,560 - $738,865	-5,392 Reduced 7.81%	63,630 $8.43 Million
Q1 2018 May 15, 2018	BUY	$103.82 - $123.9 $1.75 Million - $2.09 Million	16,844 Added 32.28%	69,022 $8.15 Million
Q4 2017 Feb 14, 2018	BUY	$111.14 - $123.05 $1.14 Million - $1.27 Million	10,290 Added 24.57%	52,178 $5.85 Million
Q3 2017 Nov 14, 2017	BUY	$101.4 - $116.62 $4.25 Million - $4.88 Million	41,888	41,888 $4.77 Million

Others Institutions Holding ICLR

# of Institutions

702

Shares Held

75.6M

Call Options Held

169K

Put Options Held

58.4K

View Full List

About ICON PLC

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $17.4B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

More about ICLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account